Dean L. Schorno
Executive VP & CFOMr. Dean L. Schorno, C.P.A serves as the Executive Vice President and Chief Financial Officer at Rigel Pharmaceuticals Inc. since May 30, 2018. Mr. Schorno served as the Chief Financial Officer and Head of Operations at 23andMe, Inc. in August 2015. Mr. Schorno held distinguished leadership positions at Genomic Health spanning financial, laboratory, and business operations. Before joining 23andMe, he served as the Chief Financial Officer of Adaptive Biotechnologies Corporation from June 19, 2014 to August 10, 2015. During this time, he led financial operations through periods of significant business and commercial growth which included significant financing and commercial transaction activity. He served as the Chief Financial Officer of Genomic Health Inc. from January 3, 2011 to June 13, 2014 and served as its Principal Accounting Officer from January 3, 2011 to June 2014. He served as Consultant of Genomic Health Inc. since June 2014. He served as Senior Vice President of Finance at Genomic Health Inc. from February 2010 to January 3, 2011 and also served as its Vice President of Finance from August 2008 to February 2010 and Vice President of Operations from January 2004 to August 2008. From July 2001 to December 2003, he led Genomic Health Inc.’s finance group as a Director and Senior Director. Prior to Genomic Health, he founded and led a CPA and consulting firm and headed it from 1991 to 2001. Mr. Schorno began his career in finance at an international accounting firm in San Francisco, CA before starting his own consultancy in 1991. From 1985 to 1991, he worked at an International Accounting Firm. Mr. Schorno is a Certified Public Accountant and holds a Bachelor of Science degree in Business Administration, from the University of California, Berkeley and Master of Science in Taxation from the Golden Gate University.
Positions
- Company NameRigel Pharmaceuticals, Inc.Stock CodeRIGLPositionExecutive VP & CFOColleagues
- RRRaul R. RodriguezPresident, CEO & Director
- GAGregory Anthony LapointeIndependent Chairman of the Board
- RJRaymond J. FureyExecutive VP, Chief Compliance Officer, General Counsel & Corporate Secretary
- DADavid A. SantosExecutive VP & Chief Commercial Officer
- ALAlison L. HannahExecutive VP & Chief Medical Officer
- WHWalter H. MoosIndependent Director
- JWJane WasmanIndependent Director
- KAKamil Ali JacksonIndependent Director
